Varilrix 0.5 ml Powder for solution and injection.

Indication

Active immunisation against varicella in healthy infants, children, adolescents, and high-risk patients.

Dosage (summary)

0.5 ml for healthy subjects; 2 doses for ages 9 months to 12 years and for 13 years and above, with a minimum interval of 4 weeks.

Special Populations

• Immunocompromised patients
• Patients with chronic diseases
• High-risk patients

Pregnancy & Breastfeeding

Contraindicated in pregnancy; avoid pregnancy for 1 month post-immunisation; not advised during breastfeeding.

Key Drug Interactions

• Avoid salicylates for 6 weeks post-vaccination
• Delay vaccination after immune globulin or blood transfusion for 3 months

Contraindications

• Severe immunodeficiency
• Hypersensitivity to neomycin or components
• Pregnancy

Common side effects

• Pain at injection site
• Fever
• Rash
• Lymphadenopathy

Counselling Points

• Inform about potential mild varicella breakthrough cases
• Advise on injection site care
• Discuss the importance of completing the vaccination schedule